Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.810
-0.140 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
4.790
-0.020 (-0.42%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Chimerix Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $294.63 million as of August 1, 2025. Its market cap has decreased by -1.05% in one year.
Market Cap
294.63M
Enterprise Value
10.42M
1-Year Change
-1.05%
Ranking
Category
Stock Price
$4.81
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $294.63M, a decrease of -65.15%. That is a compound annual growth rate of -22.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 304.47M | -28.59% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.35B |
| Johnson & Johnson | 403.32B |
| AbbVie | 345.99B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.49B |
| UnitedHealth Group | 214.62B |
| Novo Nordisk | 211.90B |